Zhejiang inCarey Pharmaceutical Technology Co., Ltd. announced that it has completed a US$30 million series B+ round of financing, with the exclusive investment of Long Hill Capital. China Renaissance Capital acted as the exclusive financial advisor for this round of financing. On August 5th, Livongo and Teladoc Health, the two digital healthcare giants in the […] Chinese Chronic Disease Management Startup inCarey Raises $30M comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.